Last reviewed · How we verify

drops intilation (Taponoto ® )

Hospital Clinic of Barcelona · FDA-approved active Small molecule

Drops intilation (Taponoto) is a medication that works by inhibiting the reuptake of dopamine and norepinephrine in the brain.

Drops intilation (Taponoto) is a medication that works by inhibiting the reuptake of dopamine and norepinephrine in the brain. Used for Excessive daytime sleepiness, Narcolepsy.

At a glance

Generic namedrops intilation (Taponoto ® )
SponsorHospital Clinic of Barcelona
Drug classDopamine-norepinephrine reuptake inhibitor
ModalitySmall molecule
Therapeutic areaNeurology
PhaseFDA-approved

Mechanism of action

This action increases the levels of these neurotransmitters in the synaptic cleft, leading to increased alertness and wakefulness. Drops intilation is used to treat excessive daytime sleepiness and narcolepsy.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results